Stem Cell Banking
Cord Blood & Tissue
Stem Cell Packages
REPRODUCTIVE HEALTH
Immunogenetics
Genome Sequencing
Oncology
Screening
Health and Wellness
Learning Resources
Training service
Reproductive Health
Organ and Tissue Transplants
Immunogenetics Health Tests
Schedule Your Consultation Today
Take the first step toward personalized, non-invasive reproductive health insights.
Ensure Compatibility for Safe, Successful Organ and Tissue Transplants
This test analyzes Human Leukocyte Antigen (HLA) markers to determine donor-recipient compatibility for organ or tissue transplantation. Accurate HLA typing supports successful organ procurement, reduces the risk of rejection, enhances long-term transplant success, and improves post-operative care and patient outcomes.
Conditions Detected by Organ and Tissue Transplants
01
HLA Compatibility
02
Graft-Versus-Host Disease (GVHD) Risk
03
Immunological Mismatch
04
Allogeneic Transplant Assessment
Precision for Transplant Success
Reduced Rejection Risk
Ensure higher match accuracy and lower chance of transplant failure.
Better Long-Term Outcomes
Improves graft survival and overall transplant success over time.
Informed Donor Matching
Supports physicians in selecting the most compatible donor for each patient through optimized organ tissue donation matching.
Streamlined Transplant Planning
Accelerates decision-making with timely, accurate HLA results.
How It Works
Genetic Matching for Lifesaving Transplants
Sample Collection
A simple blood or buccal swab sample is collected from both donor and recipient during the organ procurement or transplant preparation process.
HLA Typing Analysis
Advanced sequencing identifies specific HLA markers to assess compatibility.
Compatibility Report
Receive a detailed match report for clinical decision-making and transplant planning.
Why Choose FSG?
01
High-Resolution Typing
Our advanced molecular diagnostics deliver unmatched precision for transplant compatibility.
02
Clinical-Grade Expertise
Data reviewed by immunogenetics experts for high-stakes medical decisions.
03
Fast, Reliable Results
Timely insights to support urgent transplant timelines and planning.
04
Trusted by Professionals
FSG is the UAE’s first certified stem cell and molecular genomics laboratory, setting new standards for safe organ tissue donation and transplant support.
FAQ’s
Frequently Asked Questions!
We’re here to help. Explore answers or reach out to our team directly.
A remarkable number of organs and tissues can be successfully transplanted today, thanks to advances in organ procurement. Organs such as the heart, kidneys, liver, lungs, pancreas, and intestines are commonly transplanted. In addition, organ tissue donation makes it possible to transplant corneas, heart valves, skin, bones, tendons, and ligaments—restoring critical functions and improving quality of life for patients.
No, organ transplantation is not considered experimental. It is a proven, widely accepted medical procedure backed by decades of research and clinical success. Supported by highly structured organ procurement and organ tissue donation programs, transplantation today plays a vital role in treating patients with end-stage organ failure and severe tissue damage.
As with any major medical procedure, organ and tissue transplants carry some risks. These may include transplant rejection, infections, and side effects from immunosuppressive medications. However, with precise organ procurement, careful donor screening, and advanced matching techniques, the risks are significantly reduced, helping ensure safer, more successful organ tissue donation outcomes.
Many types of tissues and organs are used for transplantation to help patients recover health and function. Through organized organ procurement efforts, organs like the kidneys, liver, heart, and lungs are transplanted regularly. Tissues such as corneas, skin, bones, and tendons are also used in organ tissue donation to treat injuries, restore sight, and support healing in a range of medical conditions.
Non-Invasive Prenatal Testing/Screening
Pre-Implantation Genetic Testing/Screening (PGT/PGS)
Male/Female Fertility
Rapid Prenatal & Pregnancy Loss
Maternal Cell Contamination (MCC)
Product of Conception (POC)
My HLA (Human Leucocyte Antigen)
Whole Genome Sequencing (WGS)
Whole Exome Sequencing (WES)
Low Pass Sequencing (1-3x Coverage)
Comprehensive Oncology Screening
Breast Cancer Screening (BRCA)
Cervical Cancer Screening
Prostate Cancer Screening
Heredity Cancer Panel
Leukemia Panel
Lymphoma Panel
Carrier Screening
Newborn Screening
Infectious Diseases Screening
Rare Diseases Screening
Consumer Genomics
Gut Metagenomics
Metagenomics
Personalized Medicine